ArticlePatient preference and adherence2014
Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin.
Sheila A DoggrellPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it